FAP is known to be overexpressed on cancer-associated fibroblasts within the tumour microenvironment of breast, colorectal, ovarian, and other cancers, while its expression is low or undetectable normal tissues (Fitzgerald and Weiner 2020). Here, FAP is linked to neoplasm.